跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SITAGLIPTIN MAPLE sitagliptin (as hydrochloride monohydrate) 100 mg tablet blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
SITAGLIPTIN MAPLE sitagliptin (as hydrochloride monohydrate) 100 mg tablet blister pack
Approved
STANDARD
SITAGLIPTIN MAPLE sitagliptin (as hydrochloride monohydrate) 100 mg tablet blister pack
Maple Healthcare Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
f25d6f9ddf7af32b
Company
Maple Healthcare Pty Ltd
Type
Standard
Approval Details
Approval Id
f25d6f9ddf7af32b
Product Name
SITAGLIPTIN MAPLE sitagliptin (as hydrochloride monohydrate) 100 mg tablet blister pack
Artg Id
384805
Artg Name
SITAGLIPTIN MAPLE sitagliptin (as hydrochloride monohydrate) 100 mg tablet blister pack
Sponsor
Maple Healthcare Pty Ltd
Company Detail Path
/organization/maple-healthcare-pty-ltd
Artg Date
2023-04-06
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
f25d6f9ddf7af32b
Type
Standard
Back to TGA Approvals
